Incidences of adverse reactions, such as fatigue, hand and feet reactions, hypertension, elevated ALT/AST, loss of appetite, and proteinuria, during the use of anlotinib were greater than 20%, regardless of severity grade. The gene discussed is GPT; the disease is Hypertension.